2016 Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS subcommittee of the Chronic Malignancies Working Party of the EBMT. Group Chronic Malignancies Working Party (CMWP) 1st listed author Cremers EM Journal Ann Hematol.
2016 Splenic irradiation before hematopoietic stem cell transplantation for chronic myeloid leukemia: long-term follow-up of a prospective randomized study. Group Chronic Malignancies Working Party (CMWP) 1st listed author Gratwohl A Journal Ann Hematol.
2015 Efficacy and outcome of allogeneic transplantation in IgD and non secretory myeloma. A report on behalf of the myeloma subcommittee of the Chronic Malignancies Working Party of the EBMT. Group Chronic Malignancies Working Party (CMWP) 1st listed author Morris C Journal Biol Blood Marrow Transplant.
2015 Impact of allogeneic stem cell transplantation on survival of patients less than 65 years of age with primary myelofibrosis. Group Chronic Malignancies Working Party (CMWP) 1st listed author Kröger N Journal Blood
2015 Impact of CR before and after allogeneic and autologous transplantation in multiple myeloma: results from the EBMT NMAM2000 prospective trial. Group Chronic Malignancies Working Party (CMWP) 1st listed author Iacobelli S Journal Bone Marrow Transplant.
2015 Impact of the revised International Prognostic Scoring System, cytogenetics and monosomal karyotype on outcome after allogeneic stem cell transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia evolving from myelodysplastic syndromes: a retrospective multigenerational study of the European Society of Blood and Marrow Transplantation. Group Chronic Malignancies Working Party (CMWP) 1st listed author Koenecke C Journal Haematologica
2015 Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group. Group Chronic Malignancies Working Party (CMWP) 1st listed author Kröger NM Journal Leukemia
2015 Second allogeneic transplantation for relapse of malignant disease: retrospective analysis of outcome and predictive factors by the EBMT. Group Chronic Malignancies Working Party (CMWP) 1st listed author Ruutu T Journal Bone Marrow Transplant.
2014 Comparison of Unrelated Cord Blood and Peripheral Blood Stem Cell Transplantation in Adults with Myelodysplastic Syndrome after Reduced-Intensity Conditioning Regimen: A Collaborative Study from Eurocord and Chronic Malignancies Working Party. Group Other society Chronic Malignancies Working Party (CMWP) 1st listed author Robin M Journal Biol Blood Marrow Transplant.
2014 Early administration of donor lymphocyte infusions upon molecular relapse after allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia: a study by the Chronic Malignancies Working Party of the EBMT. Group Chronic Malignancies Working Party (CMWP) 1st listed author Chalandon Y Journal Haematologica
2014 Impact of the International Prognostic Scoring System cytogenetic risk groups on the outcome of patients with primary myelodysplastic syndromes undergoing allogeneic stem cell transplantation from human leukocyte antigen-identical siblings: a retrospective analysis of the European Society for Blood and Marrow Transplantation-Chronic Malignancies Working Party. Group Chronic Malignancies Working Party (CMWP) 1st listed author Onida F Journal Haematologica
2014 Improved PFS after autologous stem cell transplantation does not translate into better Quality of Life in CLL: lessons from the randomized EBMT-Intergroup study. Group Chronic Malignancies Working Party (CMWP) 1st listed author de Wreede LC Journal Am J Hematol.